SCHEMBL23931453

SCHEMBL23931453

CC(C)(C)OC(=O)N1CCC2(C=C(B3OC(C)(C)C(C)(C)O3)C2)C1

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ USP30 Q70CQ3 3/20 0.41
▸ SCD5 Q86SK9 1/20 0.38
▸ CYP11B2 P19099 1/20 0.37
▸ USP2 O75604 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ HDAC2 Q92769 2/20 0.36
▸ NR1H2 P55055 1/20 0.35
▸ ACACB O00763 2/20 0.35
▸ GPR183 P32249 1/20 0.35
▸ RORC P51449 3/20 0.34
▸ BUB1 O43683 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ LMNA P02545 1/20 0.34
▸ MAPT P10636 1/20 0.34
▸ HDAC1 Q13547 1/20 0.34
▸ PIK3CD O00329 1/20 0.33
▸ PIK3R1 P27986 1/20 0.33
▸ PIK3CA P42336 1/20 0.33
▸ PIK3CB P42338 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20396083 0.93 USP30 (0.42) USP30USP2SMN1; SMN2BUB1ALDH1A1
SCHEMBL23931390 0.90 USP30 (0.41) USP30USP2SMN1; SMN2NR1H2GPR183
SCHEMBL23931417 0.82 USP30 (0.39) USP30SCD5USP2SMN1; SMN2NR1H2
SCHEMBL19693266 0.81 SCD5 (0.42) USP30SCD5CYP11B2USP2SMN1; SMN2
SCHEMBL23584405 0.78 USP30 (0.40) USP30SCD5CYP11B2USP2SMN1; SMN2
SCHEMBL24753436 0.78 USP30 (0.40) USP30USP2SMN1; SMN2ALDH1A1LMNA
SCHEMBL20396153 0.78 USP30 (0.40) USP30USP2SMN1; SMN2HDAC2NR1H2
SCHEMBL26134743 0.77 SCD5 (0.42) USP30SCD5CYP11B2HDAC2NR1H2
SCHEMBL26963358 0.75 USP30 (0.38) USP30SCD5CYP11B2USP2SMN1; SMN2
SCHEMBL16051476 0.75 USP30 (0.40) USP30SCD5CYP11B2USP2SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025111408-A1 COMPOUNDS FOR TREATING SPINAL MUSCULAR ATROPHY AND HUNTINGTON'S DISEASE BIOGEN MA INC. (US) 2025-05-30 — — WO disclosed
WO-2021216661-A1 PYRAZOLE CARBOXAMIDE COMPOUNDS FOR TREATMENT OF HBV ASSEMBLY BIOSCIENCES, INC. (US) 2021-10-28 — — WO disclosed
WO-2021216661-A1 PYRAZOLE CARBOXAMIDE COMPOUNDS FOR TREATMENT OF HBV ASSEMBLY BIOSCIENCES, INC. (US) 2021-10-28 — — WO disclosed
Send feedback